[india-drug] Response to enquiry regarding awareness of HIN in India

[Tekur Uma <umatekur@yahoo.com>]

Response to enquiry regarding awareness of HIN in India
--------------------------------------------------------

Dear Ms. Sunitha Srinivas:
 
Yes, the HIN Project is being supervised from New Delhi and Mr. Ranjan 
Dwiwedi is the right person to give you any information about this 
project. I understand that though three states in India (Orissa,
Karnataka and Delhi) were to get the benefit of free access to some
1000 biomedical journals, it did not happen. India was excluded from
among the developing countries which were given this benefit. That is
the reason you do not find anyone accessing through this site. Dr. Ram
Raj Urs of Rajiv Gandhi Health Science University at Bangalore would be
able to give you the correct email address of Mr. Rajan Dwiwedi.

With regards
A. Ratnakar


________________________________________________________________________
Yahoo! India Mobile: Download the latest polyphonic ringtones.
Go to http://in.mobile.yahoo.com

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org